FDA DEVICE FACTS
ChitoZolve
Gyrus Acmi, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Indicated for use in patients undergoing nasal/sinus surgery as a space occupying hemostat/splint to:
- Separate tissue or structures compromised by surgical trauma
- Separate and prevent adhesions between mucosal surfaces during mesothelial cell regeneration in the nasal cavity
- Help control minimal bleeding following surgery or trauma
- Help control minimal bleeding following surgery or nasal trauma by tamponade effect blood absorption and platelet aggregation
- Act as an adjunct to aid in the natural healing process
Indicated for use as a nasal hemostat to treat epistaxis.
Intended for use under the direction of a licensed healthcare provider.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。